NVAX

#1722
Novavax, Inc. - Common Stock
10.9 7 USD
+6.30%
Setor: Cuidados de saúde
Base: USD
Moeda do lucro: USD
Faixa diária
10.97
10.97
Faixa anual
6.13
11.97
Mudança diária
+6.30%
Mudança mensal
+36.95%
Mudança em 6 meses
+60.15%
Mudança anual
+54.94%
Fechamento anterior
10.3 2
Open
10.9 7
Mínimo
10.9 7
High
10.9 7
Volume
127
Abrir gráfico completo Full chart

Financials

Visão geral Relatórios Estatísticas Dividendos
Trimestral Ano
Demonstração de resultados Balanço patrimonial Fluxo de caixa
Valor 202020212022202320242025 TTM

Novavax, Inc. - Common Stock

Novavax, Inc., based in Gaithersburg, Maryland, develops vaccines to counter infectious diseases. The company developed the Novavax COVID-19 vaccine, now commercialized by Sanofi. The company also develops vaccines for influenza, respiratory syncytial virus, avian flu, shingles, Clostridioides difficile, and malaria. Novavax develops proprietary immune-stimulating saponin-based immunologic adjuvants at a wholly owned Swedish subsidiary, Novavax AB. One of these, Matrix-M, is used in the Novavax COVID-19 vaccine.

Notícias